Positron emission tomography/computed tomography of a rare xanthogranulomatous process: Erdheim-Chester disease.

Pereira Neto CC, Roman C, Johnson M, Jagasia M, Martin WH, Delbeke D
Mol Imaging Biol. 2004 6 (1): 63-7

PMID: 15018830 · DOI:10.1016/j.mibio.2004.01.023

Erdheim-Chester disease (ECD) is a disseminated xanthogranulomatous infiltrative disease of unknown etiology due to infiltration of different organs and bones by foamy histiocytes. A 37-year-old male with cerebral and periorbital lesions was diagnosed with this rare disease and was evaluated with magnetic resonance imaging (MRI) and 2-deoxy-2-[(18)F]fluoro-D-glucose (FDG) with positron emission tomography/computed tomography (PET/CT) imaging at baseline and following therapy. FDG-PET imaging allowed accurate evaluation of the extent of the disease at baseline, as well as assessment of response to therapy.

MeSH Terms (9)

Adult Erdheim-Chester Disease Fluorodeoxyglucose F18 Humans Magnetic Resonance Imaging Male Prognosis Tomography, Emission-Computed Xanthomatosis

Connections (1)

This publication is referenced by other Labnodes entities: